Ironwood Pharmaceuticals
IRWD
#7145
Rank
A$0.87 B
Marketcap
A$5.31
Share price
-2.11%
Change (1 day)
325.57%
Change (1 year)

Earnings for Ironwood Pharmaceuticals (IRWD)

Earnings in 2026 (TTM): A$0.25 Billion

According to Ironwood Pharmaceuticals 's latest financial reports the company's current earnings are A$0.36 Billion. In 2025 the company made an earning of A$0.10 Billion, an increase over its 2024 earnings that were of A$93.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ironwood Pharmaceuticals from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.25 B154.54%
2025 A$0.10 B7.4%
2024 A$93.36 M-106.88%
2023 -A$1.36 Billion-475.59%
2022 A$0.36 B25.8%
2021 A$0.28 B84.32%
2020 A$0.15 B84.69%
2019 A$84.4 M-125.13%
2018 -A$0.34 Billion100.62%
2017 -A$0.17 Billion43.12%
2016 -A$0.12 Billion-42.73%
2015 -A$0.21 Billion-24.76%
2014 -A$0.28 Billion-30.49%
2013 -A$0.4 Billion275.65%
2012 -A$0.11 Billion11.56%
2011 -A$93.23 Million9.38%
2010 -A$85.23 Million-15.21%
2009 -A$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
A$20.99 B 8,451.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Nektar Therapeutics
NKTR
-A$0.22 Billion-188.77%๐Ÿ‡บ๐Ÿ‡ธ USA